A genome-scale CRISPR knock-out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 13/01/2021